Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TEBENTAFUSP-TEBN vs TECLISTAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TEBENTAFUSP-TEBN vs TECLISTAMAB: Safety Overview

Metric TEBENTAFUSP-TEBN TECLISTAMAB
Total FAERS Reports 350 1,221
Deaths Reported 45 269
Death Rate 12.9% 22.0%
Hospitalizations 112 540
Average Patient Age 68.3 yrs 66.5 yrs
% Female Patients 53.0% 45.7%
Manufacturer N/A Janssen Biotech, Inc.
Route N/A SUBCUTANEOUS
Marketing Status Prescription N/A